Advertisement

Molecular Biology Reports

, Volume 43, Issue 7, pp 751–751 | Cite as

Retraction Note to: Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study

  • Qing Zhu
  • Tongtao LiuEmail author
Retraction Note

Retraction Note to: Mol Biol Rep (2012) 39:8679–8685 DOI 10.1007/s11033-012-1723-8

The Editor-in-Chief of Molecular Biology Reports retracts the above-mentioned article per the Committee on Publication Ethics guidelines on plagiarism. The article duplicates (copies) significant paragraphs from the following main source/sources:

Lan Ma, Haifeng Zhang, Carrie Han, Danian Tong, Meiyan Zhang, Yi'an Yao, Yu Luo, and Xuebo Liu, Fibroblast Growth Factor Receptor 4 Polymorphisms and Susceptibility to Coronary Artery Disease, DNA and Cell Biology. June 2012, 31(6): 1064-1069. doi: 10.1089/dna.2011.1552.

Chen H, Tong J, Zou T, Shi H, Liu J, Du X, Yang J, Ma C, Fibroblast growth factor receptor 4 polymorphisms are associated with coronary artery disease. Genet Test Mol Biomarkers, 16:952–956, 2012.

These two articles were submitted within a relatively short time from each other which constitutes duplicate submission. In addition, further investigation showed irregularities in the peer review process leading us to believe that the peer review process was compromised.

Copyright information

© Springer Science+Business Media Dordrecht 2016

Authors and Affiliations

  1. 1.Department of CardiologyQilu Hospital, Shandong UniversityJinanChina

Personalised recommendations